Working… Menu

Pharmacodynamic Study of Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients With Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03936933
Recruitment Status : Unknown
Verified May 2019 by Eurofarma Laboratorios S.A..
Recruitment status was:  Not yet recruiting
First Posted : May 3, 2019
Last Update Posted : May 3, 2019
Information provided by (Responsible Party):
Eurofarma Laboratorios S.A.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : February 1, 2020
Estimated Study Completion Date : November 1, 2020